Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56M Buy
1,288
+196
+18% +$312K 0.53% 50
2026
Q1
$1.44M Buy
+1,092
New +$1.5M 0.37% 64

Other funds holding ASML

Cadent Capital Advisors's ASML Position: Q2 2026 in Review

Cadent Capital Advisors increased its ASML (ASML) stake by 18% in Q2 2026, buying an estimated $312K and bringing the position to 1,288 shares worth $2.56M. The position accounts for 0.53% of the portfolio, ranked #50.

Cadent Capital Advisors first reported a position in ASML in Q1 2026 and has held it in 2 quarters since. 2,498 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Cadent Capital Advisors held 1,288 shares of ASML worth $2.56M as of Q2 2026.
  • Cadent Capital Advisors bought 196 ASML shares in Q2 2026, an estimated $312K.
  • ASML made up 0.53% of Cadent Capital Advisors's portfolio in Q2 2026, its #50 holding.
  • Cadent Capital Advisors first reported a position in ASML in Q1 2026 and has held it in 2 quarters since.
  • 2,498 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.